Bank of Montreal Portfolio holdings
Bank of Montreal (BMO), established in 1817 as Canada’s first chartered bank and headquartered in Montreal, Quebec (with key operations in Toronto), is a major North American financial institution offering personal and commercial banking, wealth management, and capital markets services. Managing hundreds of billions in assets, BMO serves over 13 million customers, with a strong U.S. presence through BMO Harris Bank, bolstered by its 1984 acquisition of Harris Bank and the 2022 purchase of Bank of the West, expanding its footprint to 32 states. Known for its longevity and stability, BMO has paid dividends since 1829, one of the longest streaks globally, and emphasizes digital innovation and sustainable finance under CEO Darryl White. With a global reach spanning North America, Europe, and Asia, BMO blends its historical roots with a modern focus on customer-centric growth.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
WBA
Walgreens Boots Alliance
WBA
|
+$226M |
| 2 |
FedEx
FDX
|
+$181M |
| 3 |
Intel
INTC
|
+$173M |
| 4 |
Restaurant Brands International
QSR
|
+$169M |
| 5 |
Mohawk Industries
MHK
|
+$153M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$335M |
| 2 |
Viatris
VTRS
|
+$233M |
| 3 |
Merck
MRK
|
+$230M |
| 4 |
Pfizer
PFE
|
+$216M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$193M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 26.32% |
| 2 | Energy | 11.41% |
| 3 | Miscellaneous | 10.53% |
| 4 | Healthcare | 9.72% |
| 5 | Technology | 9.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
SF
3001
Stifel
SF
$10.6B
| $41K | ﹤0.01% |
1,654
-661
| -29% | -$15.3K |
2013 Q2
7 quarters
|
|
3002
Tompkins Financial
TMP
$1.4B
| $41K | ﹤0.01% |
768
+128
| +20% | +$6.73K |
2013 Q2
7 quarters
|
|
|
KND
3003
DELISTED
Kindred Healthcare
KND
| $41K | ﹤0.01% |
1,699
+1,201
| +241% | +$24.4K |
2013 Q2
7 quarters
|
|
|
TFM
3004
DELISTED
THE FRESH MARKET, INC COM STK
TFM
| $41K | ﹤0.01% |
1,007
| – | – |
2013 Q2
7 quarters
|
|
3005
AZZ Inc
AZZ
$4.07B
| $40K | ﹤0.01% |
860
+307
| +56% | +$13.5K |
2013 Q2
7 quarters
|
|
3006
Hercules Capital
HTGC
$3.17B
| $40K | ﹤0.01% |
3,000
-1,407
| -32% | -$20.6K |
2013 Q2
7 quarters
|
|
3007
iShares Global Infrastructure ETF
IGF
$10B
| $40K | ﹤0.01% |
964
| – | – |
2013 Q2
7 quarters
|
|
3008
IPG Photonics
IPGP
$3.56B
| $40K | ﹤0.01% |
432
+286
| +196% | +$24.7K |
2014 Q4
1 quarter
|
|
3009
Power Integrations
POWI
$2.88B
| $40K | ﹤0.01% |
1,538
-2,500
| -62% | -$67.3K |
2013 Q2
7 quarters
|
|
|
PRO
3010
DELISTED
PROS Holdings
PRO
| $40K | ﹤0.01% |
1,611
| – | – |
2014 Q2
3 quarters
|
|
|
PRGX
3011
DELISTED
PRGX Global, Inc.
PRGX
| $40K | ﹤0.01% |
9,855
| – | – |
2013 Q3
6 quarters
|
|
|
HSNI
3012
DELISTED
HSN, Inc.
HSNI
| $40K | ﹤0.01% |
579
| – | – |
2013 Q2
7 quarters
|
|
|
SLH
3013
DELISTED
SOLERA HOLDINGS, INC. COM
SLH
| $40K | ﹤0.01% |
768
-45,176
| -98% | -$2.38M |
2013 Q2
7 quarters
|
|
|
ASCMA
3014
DELISTED
Ascent Capital Group, Inc. Series A
ASCMA
| $40K | ﹤0.01% |
1,000
| – | – |
2014 Q2
3 quarters
|
|
|
AST
3015
DELISTED
Asterias Biotherapeutics Inc. Series A
AST
| $40K | ﹤0.01% |
+6,041
| New | +$29.9K |
2015 Q1
0 quarters
|
|
3016
Acadia Realty Trust
AKR
$2.57B
| $39K | ﹤0.01% |
1,131
+396
| +54% | +$13.8K |
2013 Q2
7 quarters
|
|
3017
Altisource Portfolio Solutions
ASPS
$70.5M
| $39K | ﹤0.01% |
+375
| New | +$62.5K |
2015 Q1
0 quarters
|
|
|
BRW
3018
Saba Capital Income & Opportunities Fund
BRW
$309M
| $39K | ﹤0.01% |
3,551
-226
| -6% | -$2.44K |
2013 Q2
7 quarters
|
|
3019
Digi International
DGII
$2.79B
| $39K | ﹤0.01% |
3,860
| – | – |
2013 Q2
7 quarters
|
|
3020
State Street SPDR S&P Emerging Markets Small Cap ETF
EWX
$657M
| $39K | ﹤0.01% |
870
| – | – |
2013 Q4
5 quarters
|
|
3021
Fortress Biotech
FBIO
$69M
| $39K | ﹤0.01% |
+667
| New | +$27.8K |
2015 Q1
0 quarters
|
|
|
IGR
3022
CBRE Global Real Estate Income Fund
IGR
$585M
| $39K | ﹤0.01% |
1,467
-333
| -19% | -$9.1K |
2014 Q3
2 quarters
|
|
3023
Saic
SAIC
$5.29B
| $39K | ﹤0.01% |
760
+541
| +247% | +$28.3K |
2013 Q4
5 quarters
|
|
3024
Silicon Laboratories
SLAB
$7.42B
| $39K | ﹤0.01% |
771
+222
| +40% | +$10.8K |
2013 Q2
7 quarters
|
|
3025
Vanguard Russell 3000 ETF
VTHR
$4.79B
| $39K | ﹤0.01% |
405
| – | – |
2014 Q2
3 quarters
|
|
Similar funds
Bank of Montreal's Q1 2015 Portfolio in Review
As of Q1 2015, Bank of Montreal held 4,475 positions worth $86.3B, down 2.1% from $88.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Bank of Montreal's Q1 2015 filing shows 379 new, 1,429 increased, 1,543 reduced and 407 closed positions. Its largest new stake was Walgreens Boots Alliance: 2,840,150 shares worth $241M. The largest sale was Apple, an estimated $335M.
By sector, the portfolio is most concentrated in Financials at 26% of assets, down from 27% a quarter earlier, followed by Energy and Miscellaneous.
- Bank of Montreal's largest Q1 2015 buy was Walgreens Boots Alliance: 2,840,150 shares worth $241M.
- Bank of Montreal added most to FedEx in Q1 2015, an estimated $181M increase.
- Bank of Montreal's biggest Q1 2015 reduction was Apple, cutting an estimated $335M.
- Bank of Montreal fully exited Allergan Inc in Q1 2015, selling an estimated $54.9M.
- Bank of Montreal's ten largest holdings make up 23% of its $86.3B portfolio in Q1 2015.
- Bank of Montreal opened 379 new positions and closed 407 in Q1 2015.
- Bank of Montreal's portfolio value fell 2.1% quarter-over-quarter to $86.3B.
Based on Bank of Montreal's 13F filing for Q1 2015, filed 13 May 2015.